Visiomed Group SA (FR:ALKLH) has released an update.
Visiomed Group SA reports robust growth in the first half of 2024 with a 23% increase in revenues to €7.9 million and a significant leap in normalized EBITDA, which is up by 135% to €1.8 million, compared to the first half of 2023. The growth is attributed to Smart Salem’s expanding test volumes and a substantial rise in Wellness business revenues, which now contribute around 5% to the Group’s sales. The company expects continued growth and profitability in the latter half of the year.
For further insights into FR:ALKLH stock, check out TipRanks’ Stock Analysis page.
